Nydiagnosticeret melanom diagnosticeret på basis af kutanediagnosticeret på basis af kutane bivirkninger efter COVID-19-bivirkninger efter COVID-19- vaccinationvaccination
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Dokumenter
- Fulltext
Forlagets udgivne version, 329 KB, PDF-dokument
While the Danish Health Authority has withdrawn the vaxzevria vaccine from the Danish vaccination programme due to reports of rare cases of severe side effects, this case report presents a potential beneficial side effect of this vaccine. A patient presented, three days after her first jab, with localized itching and bleeding from a pigmented tumour on her lower leg, which was therefore excised, and, unexpectedly, diagnosed as a melanoma. We speculate if the vaccine-induced immune reaction resulted in increased immune activity within the tumour environment, and thus facilitated the early diagnosis of melanoma.
Bidragets oversatte titel | Newly diagnosed melanoma diagnosed on the basis of cutaneous side effects from COVID-19 vaccine |
---|---|
Originalsprog | Dansk |
Artikelnummer | V01220060 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 22 |
Antal sider | 5 |
ISSN | 0041-5782 |
Status | Udgivet - 2022 |
- COVID-19/prevention & control, COVID-19 Vaccines, Early Detection of Cancer, Female, Humans, Melanoma/diagnosis, Skin Neoplasms/diagnosis
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-05/v01220060_web.pdf
Forlagets udgivne version
ID: 325712476